LY9 (SLAMF3) is an immune coreceptor regulating T/NK-cell activation and cytokine release, thereby shaping the inflammatory milieu that can interface with adiposity and downstream microvascular injury (consistent with its methylation signal in diabetic nephropathy) [43, 44]. The gene discussed is LY9; the disease is diabetic kidney disease.